MusclePharm Corp (OTCQB:MSLP)

0.90
Delayed Data
As of Feb 23
 +0.025 / +2.86%
Today’s Change
0.37
Today|||52-Week Range
2.25
+38.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues26.0M26.0M26.2M24.4M
 
 
 
 
 
Cost of Goods Sold20.5M22.8M21.2M16.4M
 
 
 
 
 
Depreciation And Amortization469.0K420.0K370.0K400.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.1M2.8M4.6M7.6M
 
 
 
 
 
General Expenses6.1M5.4M5.6M8.9M
 
 
 
 
 
Other Operating Expenses-9.9M-449.0K-22.0K0.00
 
 
 
 
Research And Development205.0K137.0K152.0K199.0K
 
 
 
 
 
Total Operating Expenses17.2M28.2M27.1M25.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.9M-2.1M-930.0K-1.3M
 
 
 
 
 
Extraordinary Credit970.0K0.000.000.00
 
 
Extraordinary Charge--0.00-1.5M0.00
 
 
Interest Expense On Debt1.1M685.0K711.0K854.0K
 
 
 
 
 
Other Expenses219.0K-293.0K21.0K-4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.0M-3.1M-3.1M-2.1M
 
 
 
 
 
Income Taxes-180.0K-28.0K-76.0K-14.0K
 
 
 
 
 
Net Income8.8M-3.1M-3.1M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.1M13.8M13.8M13.9M
 
 
 
 
 
Shares To Calculate EPS Diluted14.1M13.8M13.8M13.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.62-$0.23-$0.23-$0.15
 
 
 
 
 
EPS Diluted$0.62-$0.23-$0.23-$0.15